ECM
VCYT icon

ExodusPoint Capital Management’s Veracyte VCYT Stock Holding History

ExodusPoint Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,300
Closed -$1.61M – 2643
2020
Q4 		$1.61M Buy
+32,300
New +$1.5M 0.02% 632

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

ExodusPoint Capital Management's VCYT Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 22,939 shares — an estimated $966K sold.

ExodusPoint Capital Management first reported a position in VCYT in Q4 2020 and held it in 13 quarters. The position peaked at $25M in Q3 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 22,939 Veracyte shares in Q1 2026, an estimated $966K.
  • ExodusPoint Capital Management first reported a position in Veracyte in Q4 2020 and held it in 13 quarters.
  • ExodusPoint Capital Management's Veracyte position peaked at $25M in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.